Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand

BACKGROUND: Approximately 4 million of people are co-infected with HIV and Hepatitis B virus (HBV). In resource-limited settings, the majority of HIV-infected patients initiate first-line highly active antiretroviral therapy containing lamivudine (3TC-containing-HAART) and long-term virological resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamduang, Woottichai, Gaudy-Graffin, Catherine, Ngo-Giang-Huong, Nicole, Jourdain, Gonzague, Moreau, Alain, Luekamlung, Nuananong, Halue, Guttiga, Buranawanitchakorn, Yuwadee, Kunkongkapan, Sura, Buranabanjasatean, Sudanee, Lallemant, Marc, Sirirungsi, Wasna, Goudeau, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409123/
https://www.ncbi.nlm.nih.gov/pubmed/22860080
http://dx.doi.org/10.1371/journal.pone.0042184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409123/
https://www.ncbi.nlm.nih.gov/pubmed/22860080
http://dx.doi.org/10.1371/journal.pone.0042184

Ejemplares similares